Target intelligence / Profile preview

Human papillomavirus type 31 L1 protein

Molecular classification
Capsid protein, Viral protein
01

Overview

The Human papillomavirus type 31 (HPV31) L1 protein is the major capsid protein of HPV31, a member of the Papillomaviridae family. It plays a central role in forming the viral capsid and is essential for virus infectivity, immunogenicity, and vaccine development. Recombinant expression of L1 leads to spontaneous assembly into virus-like particles (VLPs), which mimic native virions but lack genetic material. These VLPs are highly immunogenic and form the basis for prophylactic vaccines targeting multiple oncogenic HPVs including type 31. Vaccines based on L1 induce neutralizing antibodies that prevent infection by blocking initial attachment or entry steps.

02

Mechanism of action

L1 protein is the antigen in prophylactic HPV vaccines, inducing neutralizing antibodies that prevent viral infection by blocking attachment or entry.

03

Biological functions

Viral capsid formationViral DNA encapsidationHost cell attachmentViral entryImmunogenicity
04

Disease associations

InfectionCancer (cervical, anal, oropharyngeal, etc.)
05

Safety considerations

Variability in surface-exposed loops can enable immune evasion by some variants, posing a challenge for broad-spectrum vaccine design.
06

Interacting drugs

Gardasil

Beyond the preview

Go deeper on Human papillomavirus type 31 L1 protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human papillomavirus type 31 L1 protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call